Company Announcements

Notice of Q2 and Interim Results

Source: RNS
RNS Number : 6197J
Benchmark Holdings PLC
28 April 2022

Benchmark Holdings plc


("Benchmark" or the "Company")


Notice of Q2 and Interim Results

Webcast for analysts and institutional investors

Equity Development webcast for retail investors



Benchmark Holdings plc (AIM: BMK), the aquaculture health, advanced nutrition, and genetics business, will announce its Q2 and Interim results, for the three and six month periods ended 31 March 2022, on Wednesday 18 May 2022. 


Webcast for analysts and institutional investors at 9am UK time


Trond Williksen, Chief Executive Officer and Septima Maguire, Chief Financial Officer will host a webcast for analysts and institutional investors on that day at 9am UK time. Details will be sent out separately. If you have any questions, please contact Charlie Protheroe at MHP Communications on 020 3128 8990 or email


Equity Development investor presentation for retail investors at 2pm UK time


Trond Williksen, Chief Executive Officer and Septima Maguire, Chief Financial Officer will host a separate webcast for retail investors and wealth managers at 2pm UK time. The webcast is free and open to all existing and potential shareholders. Questions can be submitted during the presentation to be addressed at the end.


To register for the event, please click here.


A recording of the event will be available afterwards here.


For further information please contact Hannah Crowe / Matt Evans: 020 7065 2692.



For further information, please contact:


Benchmark Holdings plc

Tel:  +44 (0) 114 240 9939  

Trond Williksen, CEO


Septima Maguire, CFO


Ivonne Cantu, Investor Relations




Numis (Broker and NOMAD)

Tel:  020 7260 1000

James Black, Freddie Barnfield, Duncan Monteith




MHP Communications

Tel:  020 3128 8990

Katie Hunt, Reg Hoare, Charlie Protheroe





About Benchmark

Benchmark's mission is to enable aquaculture producers to improve their sustainability and profitability.

We bring together biology and technology, to develop innovative products which improve yield, quality and animal health and welfare for our customers. We do this by improving the genetic make-up, health and nutrition of their stock - from broodstock and hatchery through to nursery and grow out.

Benchmark has a broad portfolio of products and solutions, including salmon eggs, live feed (Artemia), diets and probiotics and sea lice treatments. Find out more at


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.